Table 2.
Distribution of pre-surgery weight related complications.
| Adults (n = 74) | Adolescents (n = 76) | P |
|---|---|---|
| Hypertension (n = 74): 49/74 (66.22%) | Hypertension (n = 76): 16/76 (21.05%) | <0.0001 |
| Dyslipidemia (n = 74): 50/74 (67.57%) | Dyslipidemia (n = 76): 21/76 (27.63%) | <0.0001 |
| Type 2 Diabetes Mellitus (n = 74): 31/74 (41.89%) | Type 2 Diabetes Mellitus (n = 76): 16/76 (21.05%) | 0.005 |
| Obstructive Sleep Apnea (n = 41): | Obstructive Sleep Apnea (n = 42) | 0.845 |
| Y: 36/41 (87.80%) | Y: 35/42 (83.33%) | |
| N: 5/41 (12.20%) | N: 7/42 (16.67%) | |
| Non-alcoholic fatty liver disease (n = 69): | Non-alcoholic fatty liver disease (n = 74) | 0.085 |
| Y: 57/69 (82.61%) | Y: 68/74 (91.89%) | |
| N: 12/69 (17.39%) | N: 6/74 (8.11%) | |
| Steatosis (n = 69): | Steatosis (n = 74): | 0.091 |
| Y: 55/69 (79.71%) | Y: 67/74 (90.54%) | |
| N: 14/69 (20.29%) | N: 7/74 (9.46%) | |
| NASH (n = 69): | NASH (n = 71): | 0.953 |
| Y: 27/69 (39.13%) | Y: 26/71 (36.62%) | |
| N: 42/69 (60.87%) | N: 45/71 (63.38%) | |
| Fibrosis (n = 65): | Fibrosis (n = 71): | 0.305 |
| Y: 32/66 (48.48%) | Y: 27/71 (38.03%) | |
| N: 34/66 (51.52%) | N: 44/71 (61.97%) |
NASH, non-alcoholic steatohepatitis. Bold value means statistically significant.